DNA nanobots coming to your bloodstream

Bar Ilan University's Dr. Ido Bachelet is developing nanobots from DNA sequences for treating cancer.

Billions of robots built from DNA can live inside a syringe, and can be injected into the body, where they carry out search and destroy missions as they interact with the body and with each other. They locate tumors, release medications at the right place and in the right dosage, link up with each other to create a bridge on which tissue can grow, and with the press of an external button, they can disappear. This isn't science fiction, but applications of the nanobot technology developed by Dr. Ido Bachelet of Bar Ilan University.

Bachelet, a fresh acquisition from the Massachusetts Institute of Technology (MIT) under the reverse the brain drain program, says, "The pharmaceutical industry is constantly talking about better medicines, meaning medication which can be controlled. It's a bit like talking about a better gun, which only kills bad people. What would happen if we could give the rifle to a soldier who is trained to shoot exactly at the right time?"

Speaking at the TEDMED Israel conference, organized by Adv. Yaron Eliram and Dr. Eitam Eliram, in April, Bachelet held up a syringe, and said, "Here are 100 billion tiny robots, 50 nanometers in length. They were created in my joint work with Prof. Shawn Douglas, but at the Bar Ilan laboratory, we worked to make them more stable and safer."

How are nanometer robots produced? First, produce a DNA sequence of your choice, then replicate it using the origami DNA method. With this technique, a person can give orders to a computer to fold the DNA molecules as required. The result is, for example, a DNA sequence in the form of an oyster, whose pearl is medication, but the DNA includes a code that is activated when it comes into contact with particular materials in the body. For example, it is possible to ensure that the oyster receives a signal to change its shape and release the medication only when it encounters a tumor cell.

The molecules can also receive signals from each other. For example, it is possible to send two oysters, each of which has a different medication, both of which are essential, but are toxic when combined. Scientists can make sure that one oyster opens while the other stays closed.

"It is possible to ensure that there will be billions of molecules which react with each other. For example, it is possible to ask then to 'count', using chemicals, how many similar molecules are in their area, and then, when they reach a certain concentration, the oysters do not open. This protects the body from high concentrations of the drug," says Bachelet. He says that the processes of mutual signaling and counting give the accumulated robots the capabilities of a computer. "We create clusters of robots, which together operate the laws of logic at the level of an eight-kilobit computer, like the camcorder I had when I was a kid."

In theory, these robots can change their shape in response to signals from the body and link up with each other. When they reach the area of a wound, they can link up to become a bridge over the wound and excrete growth factors to encourage healing.

Another possibility is to send these robots through the body to seek tissues with particular characteristics, such as tumors.

Miniature antennas

This is not all. It is possible to include with the nanometer-sized DNA molecule a miniature antenna. When the antenna receives a signal, it causes a tiny change in the molecule, telling it to open or close, self-destruct, or attach to another molecule. The signal is sent from a transmitter outside the body, and the process is remotely controlled via the Internet.

Bachelet's nanobots can already carry out some of these interactions between each other, but what about interacting with the body? In the lab, Bachelet tests this on an unexpected lab animal - cockroaches.

"It is easy to work with them. You put them into the freezer for seven minutes, and they fall asleep. You inject the robots, thaw the cockroaches out, and they behave normally," says Bachelet. At this point, it is possible to see how and when the medication is excreted inside the cockroach, and it turns out that it is excreted where the researchers planned.

Published by Globes [online], Israel business news - www.globes-online.com - on May 27, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Dr. Adi Tzoref-Lorenz credit: Jonathan Bloom "My research says I don't accept there is no answer"

The death of a cancer patient spurred Dr. Adi Tzoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Record public company profits  credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Advs. Roy Keidar and Netanella Treistman credit: Nicky Westphal AI blind spot startups can no longer afford to ignore

How AI governance can assist startups and enhance their ability to succeed.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Donald Trump speaking on the deck of the USS Gerald R. Ford  at its launch in 2017 credit: Reuters/Jonathan Ernst Houthis between hammer and anvil

President Trump appears determined to end the Houthi threat to shipping, while Iran has abandoned the last active arm of its "axis of resistance."

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

Dop Elbit banner at London's Allianz HQ credit: Reuters PA Images Violence against Israeli defense cos in UK escalates

"The Sunday Times" has investigated Palestine Action, a radical left-wing group that targets Israeli defense companies, their subsidiaries, and corporations and banks with any connection to Israel.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018